По вашему запросу найдено документов: 23

Страница 1 из 3

The Role of Hydrogen Sulfide in the Localization and Expression of p53 and Cell Death in the Nervous Tissue in Traumatic Brain Injury and Axotomy
Rodkin, Stanislav, Nwosu, Chizaram, Raevskaya, Margarita, Khanukaev, Maxim, Bekova, Khava, Vasilieva, Inna, Vishnyak, Diana, Tolmacheva, Anastasia, Efremova, Elena, Gasanov, Mitkhat, Tyurin, Anton (2023)
and a classic inhibitor (aminooxyacetic acid, AOAA) of cystathionine β-synthase (CBS), which is a key
Treatment of Metastatic Renal Cell Carcinoma with Checkpoint Inhibitors in Clinical Practice in the Volga-Ural Region of the Eurasian Continent
Rakhimov, Radmir R., Sultanbaev, Aleksandr V., Izmailov, Adel A., Menshikov, Konstantin V., Zabelin, Vadim M., Izmailov, Albert A., Izmailov, Albert A., Izmailova, Svetlana M., Bakhtiyarova, Ksenia S., Izmailova, Angelina A., Gilyazova, Irina R. (2023)
. The introduction of checkpoint inhibitors has changed the paradigm of treatment of patients with malignant
РЕЗИСТЕНТНОСТЬ К ИНГИБИТОРАМ КОНТРОЛЬНЫХ ТОЧЕК ИММУНИТЕТА В ЛЕЧЕНИИ МЕТАСТАТИЧЕСКОГО РАКА ПОЧКИ
RESISTANCE TO IMMUNE CHECKPOINT INHIBITORS IN THE TREATMENT OF METASTATIC RENAL CANCER
Izmailov, A.A., Rakhimov, R.R., Sultanbayev, A.V., Menshikov, K.V., Gilyazova, I.R., Zabelin, V.M., Izmailov, A.A., Измайлов, А.А., Рахимов, Р.Р., Султанбаев, А.В., Меньшиков, К.В., Гилязова, И.Р., Забелин, В.М., Измайлов, А.А. (2023)
RESISTANCE TO IMMUNE CHECKPOINT INHIBITORS IN THE TREATMENT OF METASTATIC RENAL CANCER
Exosomal MicroRNA Levels Associated with Immune Checkpoint Inhibitor Therapy in Clear Cell Renal Cell Carcinoma
Ivanova, Elizaveta, Asadullina, Dilara, Gilyazova, Gulshat, Rakhimov, Radmir, Izmailov, Adel, Pavlov, Valentin, Khusnutdinova, Elza, Gilyazova, Irina (2023)
Immunotherapy with immune checkpoint inhibitors (ICIs) has shown high efficiency in clear cell
Enhancers of mesenchymal stem cell stemness and therapeutic potency
Al-Azab, Mahmoud, Idiiatullina, Elina, Safi, Mohammed, Hezam, Kamal (2023)
mTOR Inhibitors
Clinical and Genetic Characteristics of Calvarial Doughnut Lesions with Bone Fragility in Three Families with a Reccurent SGMS2 Gene Variant
Elena, Merkuryeva, Tatiana, Markova, Anton, Tyurin, Diana, Valeeva, Vladimir, Kenis, Maria, Sumina, Igor, Sorokin, Olga, Shchagina, Mikhail, Skoblov, Maria, Nefedova, Rita, Khusainova, Ekaterina, Zakharova, Dadali, Elena, Kutsev, Sergey (2023)
of which is sphingomyelin synthase 2, which primarily contributes to sphingomyelin (SM) synthesis—the main
АЛЛОГЕННЫЙ БИОМАТЕРИАЛ – ИНГИБИТОР ФИБРОЗА В ИШЕМИЧЕСКИ ПОВРЕЖДЕННОМ МИОКАРДЕ
Allogeneic biomaterial: a fibrosis inhibitor in ischemic myocardial damage
Лебедева, А.И., Гареев, Е.М., Афанасьев, С.А., Кондратьева, Д.С., Муслимов, С.А., Попов, С.В., Lebedeva, A.I., Gareev, E.M., Afanasiev, S.A., Kondratyeva, D.S., Muslimov, S.A., Popov, S.V. (2023)
Allogeneic biomaterial: a fibrosis inhibitor in ischemic myocardial damage
Заболевания спектра оптиконевромиелита (ЗСОНМ) – диагностические критерии и подходы к терапии
Diagnostic criteria and treatment of neuromyelitis optica spectrum disorders (NMOSD)
Simaniv, T.O., Bakhtiyarova, K.Z., Belova, A.N., Goncharova, Z.A., Sivertseva, S.A., Spirin, N.N., Totolyan, N.A., Trushnikova, T.N., Turova, E.L., Khaibullin, T.I., Sherman, M.A., Симанив, Т.О., Бахтиярова, К.З., Белова, А.Н., Гончарова, З.А., Сиверцева, С.А., Спирин, Н.Н., Тотолян, Н.А., Трушникова, Т.Н., Турова, Е.Л., Хайбуллин, Т.И., Шерман, М.А., Бойко, А.Н. (2023)
Complement C5 inhibitors
Effects of Angiotensin Receptor-Neprilysin Inhibitors (ARNIs) on the Glucose and Fat Metabolism Biomarkers Leptin and Fructosamine
Bernhard, Ohnewein, Zornitsa, Shomanova, Vera, Paar, Albert, Topf, Peter, Jirak, Lukas, Fiedler, Christina, Granitz, Vincent, Van Almsick, Dilvin, Semo, Naufal, Zagidullin, Anna-Maria, Dieplinger, Juergen, Sindermann, Holger, Reinecke, Uta, C Hoppe, Rudin, Pistulli, Lukas, J Motloch (2023)
. Angiotensin-Receptor-Neprilysin-Inhibitors (ARNIs) are an established HFrEF therapy which increases
Возможности иммунотерапии метастатического рака шейки матки
Immunotherapeutic options for management of metastatic cervical cancer
Menshikov, Konstantin V., Sultanbaev, Alexander V., Musin, Shamil I., Menshikovа, Irina А., Sultanbaeva, Nadezda I., Chashchin, Aleksandr V., Lipatov, Danila О., Izmailov, Adel А., Меньшиков, К.В., Султанбаев, А.В., Мусин, Ш.И., Меньшикова, И.А., Султанбаева, Н.И., Чащин, В.А., Липатов, Д.О., Измайлов, А.А. (2023)
PD-L1/PD-1 inhibitors

Страница 1 из 3

Google Scholar
OpenDoar

Фасеты

Авторы
Ключевые слова
Год